Jörn‐Sven Kühl - Concepedia

Author

Jörn‐Sven Kühl

Charité - Universitätsmedizin Berlin ORCID

Also Known As

J Kuhl, J Kühl, J S Kühl, J. -S. Kühl, J. Kühl, J. S. Kuhl, J. S. Kühl, J.-S. Kühl, J.S. Kühl, Jörn-Sven Kühl

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin University Hospital Leipzig Universität Hamburg Medizinische Hochschule Hannover University Medical Center Freiburg

About

Jörn‐Sven Kühl is an author at Charité - Universitätsmedizin Berlin specializing in medicine, hematology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	601
2	Health Sciences	2	2	92
3	Natural Sciences	1	1	13
4	Allergy	1	1	35
5	Biochemistry	1	1	13

Jörn‐Sven Kühl

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients Samuel Groeschel, Jörn‐Sven Kühl, Annette Bley, JAMA Neurology	2016	146
Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor Holger Tönnies, Stefanie Teresa Huber, Jörn‐Sven Kühl, Blood	2003	137
Down’s syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials Michael Dördelmann, Martin Schrappe, Andreas Reiter, Leukemia Down SyndromeHematological MalignancyTreatment OutcomePediatric HematologyClinical Characteristics	1998	118
Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents Martin Schmidt‐Hieber, James D. Schwender, Werner Heinz, Haematologica	2010	107
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis Bernd Hartz, Rebecca Marsh, Kanchan Rao, Blood	2016	101
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group Arend von Stackelberg, Enrico Völzke, Jörn‐Sven Kühl, European Journal of Cancer Hematological MalignancyPediatric HematologyMedicineMixed-phenotype Acute LeukemiaHematology	2010	96
Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy Christine Duncan, Jacob R. Bledsoe, Bartosz Grzywacz, New England Journal of Medicine	2024	93
Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients Martin Mynarek, Jakub Tolar, Michael H. Albert, Bone Marrow Transplantation HematologyAllogeneic Hematopoietic SctImmunologyPathologyMedicine	2011	89
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies M.J. Dümichen, Karl Seeger, Holger N. Lode, Journal of Hospital Infection Catheter Lock SolutionControlled TrialPediatric HematologyPatient SafetyPediatrics	2012	80
Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy Jörn‐Sven Kühl, Felipe Suárez, Godfrey T. Gillett, Brain Cell TherapyNeurological DisorderTransplantation MedicineInternal CapsuleStem Cell Transplantation	2017	73

Page 1